E
EMA Events
Guest
The fifth meeting between European Medicines Agency (EMA) and The European Federation of Pharmaceutical Industries and Associations (EFPIA) is being organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations.
Its purpose is to exchange views and promote dialogue on topics of common interest, such as discussions on the IVDR implementation challenges from pharma industry perspective, on European Medicines Shortage Platform (EMSP), COVID-19 pandemic lessons learnt and resourcing/viability of the European Medicines Regulatory Network, and on a future-proof EU regulatory system (agile committee and WGs structure) and the HTA regulation and implementation progress. EFPIA will start the meeting by presenting the outcome of the ‘Report on factors affecting the location of biopharmaceutical investments and implications for European policy priorities’.
Sumber : https://www.ema.europa.eu
Its purpose is to exchange views and promote dialogue on topics of common interest, such as discussions on the IVDR implementation challenges from pharma industry perspective, on European Medicines Shortage Platform (EMSP), COVID-19 pandemic lessons learnt and resourcing/viability of the European Medicines Regulatory Network, and on a future-proof EU regulatory system (agile committee and WGs structure) and the HTA regulation and implementation progress. EFPIA will start the meeting by presenting the outcome of the ‘Report on factors affecting the location of biopharmaceutical investments and implications for European policy priorities’.
Sumber : https://www.ema.europa.eu